University of Toledo
Obstetrics & Gynecology
Dr. John P. Geisler, MD
|
|
Give Review
John P. Geisler practices Obstetrics & Gynecology. He went to Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care He received 3 awards: "Regional Top Doctor", "Meaningful Use Stage 1 Certification" and "Fellow (FACOG)". John Geisler is a published doctor and has 100 publications published. The lastest was: 'Methicillin resistant Staphylococcus aureus as a cause of chorioamnionitis.' John Geisler accepts all Medicare patients.
Publications
- 5-millimeter trocar-site bowel herniation following laparoscopic surgery.
- Treatment of advanced or recurrent Cervical cancer with Cisplatin or Cisplatin containing regimens: a cost effective analysis.
- Ovarian Cancer risk assessment: a tool for preoperative assessment.
- Robotically assisted laparoscopic radical hysterectomy compared With open radical hysterectomy.
- Robotically assisted total laparoscopic radical trachelectomy for fertility sparing in stage IB1 adenosarcoma of the cervix.
- Imiquimod in vulvar Paget's disease: a case report.
- Primary Carcinoma of the fallopian tube and epithelial ovarian Carcinoma: a case-control analysis.
- Recombinant factor VIIa to treat late radiation-induced hemorrhagic cystitis: a case report.
- Vascular endothelial growth factor staining and elevated INR in advanced epithelial ovarian Carcinoma.
- Extreme drug resistance is common after prior exposure to paclitaxel.
- Nutritional assessment using prealbumin as an objective criterion to determine whom should not undergo primary radical cytoreductive surgery for ovarian Cancer.
- Patients having prophylactic surgery for family history or known genetic mutations: why save the uterus?
- Neoadjuvant chemotherapy in vulvar Cancer: avoiding primary exenteration.
- Increasing somatostatin analogues until effective.
- Detection of epithelial ovarian Cancer using 1H-NMR-based metabonomics.
- Should we be using cimetidine to premedicate patients receiving docetaxel or paclitaxel?
- Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian Carcinoma: results of a phase II trial.
- Late recurrence of juvenile granulosa cell tumor of the ovary.
- Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal Cancer.
- Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian Cancer treated with fertility-sparing therapy.
- Inactivation of BRCA1 and BRCA2 in ovarian Cancer.
- Failure of BRCA1 dysfunction to alter ovarian Cancer survival.
- Frequency of BRCA1 dysfunction in ovarian Cancer.
- The interaction of ifosfamide and aprepitant in gynecologic malignancies.
- Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic Cancer: a phase I study.
- Nuclear receptor co-activators and HER-2/neu are upregulated in breast Cancer patients during neo-adjuvant treatment with aromatase inhibitors.
- Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in PostMenopausal women with ...
- Influence of treatment with the anti-oestrogen 3-hydroxytamoxifen (droloxifene) on plasma sex hormone levels in PostMenopausal patients with breast cancer.
- Antibody to HIV-1, HTLV-I, and HCV in three populations of rural Haitians.
- Plasma oestrogen fractions in PostMenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking.
- Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor Status.
- A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast Cancer tissue.
- Ifosfamide and carboplatin combined With 41.8 degrees C whole-body hyperthermia in patients With refractory sarcoma and malignant teratoma.
- Influence of dexaminoglutethimide, an optical isomer of aminoglutethimide, on the disposition of estrone sulfate in PostMenopausal breast cancer patients.
- Treatment with formestane alone and in combination with aminoglutethimide in heavily pretreated breast Cancer patients: clinical and endocrine effects.
- Influence of aminoglutethimide on plasma levels of estrone sulphate and dehydroepiandrosterone sulphate in PostMenopausal breast cancer patients.
- The potential for aromatase inhibition in breast Cancer prevention.
- Hot spots in dynamic (18)FET-PET delineate malignant tumor parts Within suspected WHO grade II gliomas.
- Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary.
- Does gender discrimination exist in a gynecology training program in a private hospital?
- Retrograde lymphatic metastasis of an ileal carcinoid.
- Methicillin resistant Staphylococcus aureus as a cause of chorioamnionitis.
- Tumor markers and molecular biological markers in gynecologic malignancies.
- Tunneled central venous catheters in a gynecologic oncology service: operative and short-term complications.
- In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in PostMenopausal breast cancer patients.
- Chyloperitoneum following treatment for advanced gynecologic malignancies.
- Trisomy 21 fetus co-existent with a partial molar Pregnancy: case report.
- Ovarian Carcinoma metastatic to bilateral axillary lymph nodes. A case report.
- Changes in folate Status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients.
- 5-Fluorouracil cardiotoxicity complicating treatment of stage IIB Cervical cancer--case report.
- Non-gynecologic laparoscopy in second and third trimester Pregnancy: obstetric implications.
- The great imitator: miliary peritoneal tuberculosis mimicking stage III ovarian Carcinoma.
- Ovarian Carcinoma presenting as intra-abdominal hemorrhage.
- Papillary serous Carcinoma of the cervix: ultrasonographic findings.
- Ovarian Cancer causing upper and lower urinary tract obstruction.
- Hutch paraureteral diverticulum Complicating radical hysterectomy.
- Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast Cancer.
- Five-year survival in patients with endometrioid Carcinoma of the ovary versus those with serous Carcinoma.
- Successful laparoscopic treatment of an abdominal Pregnancy in the posterior cul-de-sac.
- Methylation: a second hit in the two-hit hypothesis.
- The effect of fixation on the size, shape and summed optical density of endometrial Cancer nuclei.
- A difference in nuclear morphometry when frozen rather than fresh tissue is studied.
- Conseusus statements on prognostic factors in epithelial ovarian Carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncolog...
- Pelvic exenteration for malignant melanomas of the vagina or urethra with over 3 mm of invasion.
- Change in MIB-1 staining between primary and recurrent epithelial ovarian Cancer.
- Evaluation of DNA methylation in the Human genome: why examine it and what method to use.
- MIB-1 in endometrial Carcinoma: prognostic significance with 5-year follow-up.
- Clear cell Carcinoma of the ovary: poor prognosis compared to serous Carcinoma.
- Total colectomy in primary Ovarian cytoreduction.
- Estrogen receptor alpha and beta expression in a case matched series of serous and endometrioid adenoCarcinomas of the ovary.
- Heat shock protein 27 in the placentas of women With and Without severe preeclampsia.
- Pelvic and para-aortic lymphadenectomy in patients with endometrioid adenoCarcinoma of the endometrium.
- Robotically-assisted laparoscopic radical parametrectomy and radical vaginectomy.
- HSP27 in patients with ovarian Carcinoma: still an independent prognostic indicator at 60 months follow-up.
- Radical hysterectomy in patients 65 years of age and older.
- Brain metastases in epithelial ovarian Carcinoma.
- Extramammary Paget's disease of the vulva recurring in a skin graft.
- Using FIGO histologic grade to determine when to perform lymphadenectomies in endometrioid adenoCarcinoma of the endometrium.
- Radical hysterectomy in the elderly female: a comparison to patients age 50 or younger.
- Lack of bcl-2 persistence: an independent prognostic indicator of poor prognosis in endometrial Carcinoma.
- Proliferation index determined by MIB-1 and recurrence in endometrial Cancer.
- Estrogen and progesterone receptors in malignant mixed mesodermal tumors of the ovary.
- DNA index by image analysis in advanced endometrial Carcinoma.
- Markov texture parameters as prognostic indicators in endometrial Cancer.
- p53 expression as a prognostic indicator of 5-year survival in endometrial Cancer.
- Docetaxel extravasation causing significant delayed tissue injury.
- Estrogen and progesterone receptor Status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary.
- A study of heat shock protein 27 in endometrial Carcinoma.
- Chemotherapy for ovarian Cancer: an evidence-based approach.
- Extramammary Paget's disease With diffuse involvement of the lower female genito-urinary system.
- Malignant mixed mullerian tumor of the ovary and bilateral breast Cancer: an argument for BRCA3, or a coincidental cluster of unconnected Cancers?
- Nuclear size, shape, and density in endometrial Carcinoma: relationship to survival at over 5 years of follow-up. Does analyzing only cells occupying the G0-G1 peak ad...
- Papillary serous Carcinoma of the uterus: increased risk of subsequent or concurrent development of breast Carcinoma.
- Ovarian Cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP).
- Immunohistochemical staining of the mismatch repair gene, hMSH2, and survival in patients with ovarian Carcinoma.
- p53 as a prognostic indicator in endometrial Cancer.
- CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation Status in ovarian cancer.
- Relationship of preoperative serum CA-125 to survival in epithelial ovarian Carcinoma.
- Quantification of p53 in epithelial ovarian Cancer.
Schools
Indiana University School Of Medicine
Loyola University Med Center
St Vincent Hospital Hlthcare Center
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- Colpopexy
- Colpopexy With Robotic Assistance
- Colporrhaphy
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Fellow (FACOG)
Education
-
St Vincent Hospital and Health Care Center -
Indiana University School of Medicine -
Loyola University
Hospital
-
Mercy St. Vincent Medical Center -
ProMedica Toledo Hospital
Drug Facts
| NPI NUMBER | 1437146081 | |
| NPPES Provider LastName | GEISLER | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 436145811 | |
| NPPES Provider State | OH | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 393.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 28.0 | |
| Percent Opioid Claims | 7.12 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1437146081 |
| Last Name Of The Provider | GEISLER |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Meiuttenun C. Brown, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert Derosa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Garth D. Phibbs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tiberiu S. Avram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David H. Tullis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terrence J. Horrigan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank R. Bruening, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark A. Briel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alexis Waggoner, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Luigi O. D'Amato, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stacy Beck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shirish M. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelly J. Manahan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Podboy, MD
This Doctor is OpenDoctor Recommended.
|